Atlas Trials

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

Clinical trial NCT00333112 · COMPLETED

Trial details

NCT number
NCT00333112
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Urinary Incontinence
Start date
2006-05-01
Primary completion
2007-01-01
Enrollment
398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.